INSIGHTS ON DRUG DEVELOPMENT

• 3D Cell Culture Reveals Undetectable Drug Efficacy In Traditional Systems

  Drug discovery now targets cancer stem cells (CSCs) to achieve long-term tumor eradication, which moves beyond traditional chemotherapeutics. Discover an advanced screening platform that better predicts CSC inhibitor efficacy.

• Validation Provider Shortens The Path To Equipment Qualification

  Explore the partnership enabling Transcat to meet regulatory requirements while focusing on core R&D and accelerating the delivery of life-changing therapies.

• Using SEC For Reliable Biotherapeutic Peptide Analysis

  Discover a breakthrough in analytical performance that delivers unmatched precision, faster results, and reduced waste. This innovation sets a new standard for sustainable, high-resolution analysis.

• High-Throughput IgG Quantification Assay For Cell Line Development

  Monoclonal antibodies are revolutionizing treatment for various diseases, which include cancer and autoimmune disorders. Discover how improving production methods can reduce costs and enhance accessibility.

• Improving In Vitro Cancer Modeling

  8/2/2024

  Organ-on-a-Chip technology represents a significant advancement in drug discovery. By mimicking human physiology, Organ-Chips can enhance the predictive accuracy of preclinical models and accelerate drug development.

• Accelerating Drug Development: Flexible And Fast DNA-To-IND Programs

  7/8/2024

  Gain expert insights on how tailored approaches and innovative technologies enable fast and flexible development workflows, ultimately supporting rapid therapeutic breakthroughs.

• Simplifying Antibody-Drug Conjugate Payload Synthesis

  8/5/2025

  ADC's offer precise, targeted therapy by delivering cytotoxic agents directly to diseased cells. Learn how this method minimizes harm to healthy tissue and revolutionizes treatment for cancer.

• Inside Asymchem's Advanced R&D Capabilities In The UK

  2/12/2026

  Advanced experimentation, unified workflows, and continuous manufacturing are accelerating small‑molecule development, improving insight and creating more efficient paths from discovery to scale.

• Why DSC Testing Is A Critical Step In Developing Biosimilar Drugs

  10/3/2024

  Explore the importance of testing in the regulatory process and how tools like Differential Scanning Calorimetry (DSC) are helping to bring more biosimilars to patients in need.